Pulmonary rehabilitation: novel programmes and perspectives
https://doi.org/10.18093/0869-0189-2013-0-6-99-105
Abstract
Pulmonary rehabilitation: novel programmes and perspectives.
About the Authors
F. Yu. MukharlyamovRussian Federation
M. G. Sycheva
Russian Federation
M. A. Rassulova
Russian Federation
A. N. Razumov
Russian Federation
References
1. Чучалин А.Г. Хроническая обструктивная болезнь и сопутствующие заболевания. Пульмонология 2008; 2: 5–14.
2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3 (11): e442.
3. The global burden of disease: disability weights for diseases and conditions. 2004 update. Geneva: World Health Organisation; 2008.
4. Nici L., Donner C., Wouterz R. et al. American Thoracic Society / European Respiratory Society. Statement on pulmonary rehabilitation (2005). Am. J. Respir. Crit. Care Med. 2006; 173 (12): 1390–1413. Doi: 10.1164/ rccm.200508-1211ST.
5. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких (пересмотр 2008 г.). Пер. с англ. Под ред. А.С.Белевского. М.: Издательский холдинг "Атмосфера"; 2009.
6. Lacasse Y., Goldstein R., Lasserson T.J., Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2006; № 4: Art. No CD003793. Doi: 10.1002/14651858. CD003793.pub2.
7. Ries A.L., Bauldoff G.S., Carlin B.W. et al. Pulmonary rehabilitation. Joint American College of Chest Physicians / American Association of Cardiovascular and Pulmonary Rehabilitation Evidence-based clinical practice guidelines. Chest 2007; 131 (5, Suppl.): 4S–42S. Doi: 10.1378/chest.06-2418.
8. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких (пересмотр 2011 г.) / Пер. с англ. Под ред. А.С.Белевского. М.: Российское респираторное общество; 2012 / Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/.
9. Белевский А.С. Реабилитация в пульмонологии. Consilium Medicum 2006; 8 (10): 80–84.
10. Bestall J.C., Paul E.A., Garrod R. et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54 (7): 581–586. Doi: 10.1136/thx.54.7.581.
11. Curtis J.R., Deyo R., Hudson L.D. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49 (2): 162–170. Doi:10.1136/thx.49.2.162.
12. Jones P.W., Quirk F.H., Baveystock C.M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's respiratory questionnaire. Am. Rev. Respir. Dis. 1992; 145 (6): 1321–1327. Doi: 10.1164/ajrccm.145.6.1321
13. Dodd J.W., Hogg L., Nolan J. et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011; 66 (5): 425–429. Doi:10.1136/thx.2010.156372.
14. Schunemann H.J., Puhan M., Goldstein R. et al. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). J. COPD 2005; 2 (1): 81–89.
15. Sato S., Nishimura K., Tsukino M. et al. Possible maximal change in the SF?36 of outpatients with chronic obstructive pulmonary disease and asthma. J. COPD 2004; 41 (3): 355–365.
16. American Thoracic Society Statement. Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med 2002; 166 (1): 111–117. Doi: 10.1164/ rccm.
17. Revill S.M., Morgan M.D., Singh S.J. et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54, (3): 213–222. Doi:10.1136/thx.54.3.213.
18. American Thoracic Society, American College of Chest Physicians. ATS / ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167 (2): 211–277. Doi: 10.1164/ rccm.167.2.211.
19. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD. Eur. Respir. J. 2008; 31 (1): 204–212. Doi: 10.1183/09031936.00114307.
20. Мкртумян Э.А. Возможности использования нагрузочного теста с газовым анализом и дифференциальной диагностики одышки у пациентов кардиологической клиники: Автореф. дис. ... канд. мед. наук. М., 2009.
21. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, air-flow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350 (10): 1005–1012. Doi: 10.1056/NEJMoa 021322.
22. Авдеев С.Н. Легочная гиперинфляция у больных хронической обструктивной болезнью. Пульмонология 2006; 5: 82–96.
23. Tzani P., Aiello M., Elia D. et al. Dynamic hyperinflation is associated with poor cardivascular response to exercise in COPD patients. Respir. Res. 2011; 12 (1): 150–157.
24. Lacasse Y., Brosseau L., Milne S. et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2002; № 3: Art. No CD003793. Doi: 10.1002/14651858. CD003793.pub2.
25. Hui K.P., Hewitt A.B. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 2003; 124 (1): 94–97. Doi: 10.1378/chest.124.1.94.
26. Бузунов Р.В., Ерошина В.А., Ершина Е.В. Легочная реабилитация пациентов старших возрастных групп с хронической обструктивной болезнью легких в условиях санатория. Клин. геронтол. 2007; (3): 6–10.
27. Guell R. Home-based rehabilitation. Breathe 2008; 5 (1): 39–41.
28. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009; 33, (5): 1165–1185. (and ref. in) Doi: 10.1183/09031936.000128008.
29. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008; 32 (4): 962–969. Doi: 10.1183/09031936.00012408.
30. Аронов Д.М., Бубнова М.Г. Реальный путь снижения в России смертности от ишемической болезни сердца. Кардиосоматика 2010; 1: 11–17.
31. Мухарлямов Ф.Ю. Оптимизация программ востановительной коррекции функционального состояния организма при постинфарктном кардиосклерозе и артериальной гипертензии: Автореф. дис. ... д-ра мед. наук. М., 2009.
32. Щегольков A.M. Реабилитация больных ИБС с сопутствующей бронхолегочной патологией в условиях санатория: Автореф. дис. ... канд. мед. наук. Л.; 1990.
33. Авдеев С.Н., Баймаканова Г.Е. Сердечно-сосудистые заболевания у больных ХОБЛ: проблемы выбора лекарственных препаратов. Атмосфера. Пульмонол. и аллергол. 2008; 2: 3–.
34. Patel I. Exacerbations of chronic obstructive pulmonary disease: definition, aetiology and management. Clin. Med. 2009; 9 (2): 170–173. Doi: 10.7861/clinmedicine.9-2-170.
35. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57 (10): 847–852. Doi: 10.1136/thx.57.10.847.
36. Spencer S., Calverley P.M., Burge P.S., Jones P.W. Impact of preventing exacerbations on deterioration of health status in COPD. Eur. Respir. J. 2004; 23 (5): 698–702. Doi: 10.1183/09031936.04.00121404.
37. Puhan M.A., Gimeno7Santos E., Scharplatz M. et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; № 10: Art. No CD005305. Doi: 10.1002/14651858. CD005305.pub3.
38. Clini E.M., Crisafulli E., Costi S. et al. Effects of early inpatient rehabilitation after acute exacerbation of COPD. Respir. Med. 2009; 103 (10): 1526–1531.
39. Currie G.P., Douglas J.G. Non-pharmacologic management. Br. Med. J. 2006; 332 (7554): 1379–1381. Doi: 10.1136/bmj.332.7554.1379.
40. Guell M.R., Cejudo P., Rodriguez7Trigo G. et al. Estandares de calidad asistencial en rehabitacion respiratoria en pacientes con enfermedad pulmonar cronica. Arch. Bronconeumol. 2012 (available online). http://dx.doi.org/10.1016/j.arbres.2012.05.009
41. Green R.H., Singh S.J., Williams J., Morgan M.D.L. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001; 56 (2): 143–145. Doi: 10.1136/thx.56.2.143.
42. Mahler D.A. Pulmonary rehabilitation. Chest 1998; 113 (4): 263–268.
43. Santos C., Santos J., Morais L. et al. Pulmonary rehabilitation in COPD: Effects of two aerobic exercise intensity in patient-centered outcomes – a randomized study. Chest 2011; 140 (4-Meeting Abstracts): 853A–853A. Doi: 10.1378/chest.1119544.
44. Maltais F., LeBlanc P., Jobin J. et al. Intensity of training and physiologic adaptation in patient with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997; 155 (2): 555–561.
45. Zainuldin R., Mackey M.G., Alison J.A. Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; № 11: Art. No CD008008. Doi: 10.1002/14651858. CD008008.pub2.
46. Puhan M.A., Busching G., Schunemann H.J. et al. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2006; 145 (11): 816–825.--
47. Zwick R.H., Burghuber O.C., Dovjak N. et al. The effect of one year outpatient pulmonary rehabilitation on patients with COPD. Wien Klein. W. 2008; 120 (15–16): 1–11 (available online from retechnologies.com).
48. Breyer M.K., Breyer7Kohansal R., Funk G.S. et al. Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir. Res. 2010; 11 (1): art. 112. Doi: 10.1186/1465-9921-11-112.
49. Зодис Я.М. Немедикаментозная реабилитация больных обструктивными заболеваниями легких. Пульмонология 2000; 4: 83–87.
50. Gosselink R., De Vos J., van den Heuvel S.P. et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur. Respir. J. 2011; 37 (2): 416–425. Doi: 10.1183/09031936.00031810. (and ref. in).
51. Bernard S., Whittom F., Leblanc P. et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159 (3): 896–901.
52. Casaburi R., Kukafka D., Cooper C.B. et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127 (3): 809–817. Doi: 10.1378/chest.127.3.809.
53. Salhi B., Troosters T., Behaegel M. et al. Effects of pulmonary rehabilitation in patients with restrictive lung disease. Chest 2010; 137 (2): 273–279.
54. Mukae H., Sakamoto N., Kohno S. Idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration 2011; 81 (3): 196–205.
55. Varadi R.G., Goldstein R.S. Pulmonary rehabilitation for restrictive lung diseases. Chest 2010; 137 (2): 247–248. Doi: 10.1378/chest.09-1857.
56. Ferreira A., Garvey C., Connors G. L. et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135 (2): 442–447. Doi: 10.1378/chest.08-1458.
57. Nici L., ZuWallack R. Pulmonary rehabilitation: today and tomorrow. Breathe 2010; 6 (4): 305–311.
58. Госселинк Р., Ботт Дж., Джонсон М. и др. Физическая терапия у взрослых больных с критическими состояниями: клинические рекомендации по физической терапии критически тяжелых больных рабочей группы Европейского респираторного общества и Европейского общества интенсивной терапии. Пульмонология 2009; 2: 21–31.
Review
For citations:
Mukharlyamov F.Yu., Sycheva M.G., Rassulova M.A., Razumov A.N. Pulmonary rehabilitation: novel programmes and perspectives. PULMONOLOGIYA. 2013;(6):99-105. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-6-99-105